Form 483

Abbisko Therapeutics Co., Ltd. Form 483, 2026-03-20

FDA issued a Form 483 to Abbisko Therapeutics Co., Ltd. on 2026-03-20 with 1 public-safe observation.

483· Form 483 issuedHuman Drugs1 observation

Abbisko Therapeutics Co., Ltd. · Pudong New Area, China · Issued March 20, 2026

Overview

  • 1 public-safe observation is available for this inspection.
  • 1 structured CFR citation is represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

20 Mar 2026
21 CFR 312.50

General responsibilities of sponsors

Cited by Richard W Berning

Inspected site

ATAbbisko Therapeutics Co., Ltd.Pudong New Area, China

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 312.50Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 1 observation

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere